Synthesis of Glycoconjugate Vaccines for Candida albicans Using Novel Linker Methodology
- 29 July 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 70 (18), 7381-7388
- https://doi.org/10.1021/jo051065t
Abstract
The cell wall phosphomannan of Candida species is a complex N-linked glycoprotein with a glycan chain that contains predominantly α-linked mannose residues. However, it is the minor β-mannan component of the phosphomannan of clinically important Candida strains that provides immunological protection in animal models of fungal disease and hence holds promise as a component of conjugate vaccines. This important antigen occurs in different forms linked to the α-mannan backbone via a phosphodiester bond (acid-labile β-mannan) or directly via a glycosidic bond. To reproducibly synthesize and evaluate conjugate vaccines, a robust method for the synthesis of the different oligosaccharide epitopes is required. Here, we report the gram-scale syntheses of both types of epitopes by an approach that utilizes glucosyl trichloroacetimidate donor 2 to first create a β-glucopyranoside linkage and then epimerizes the C-2 center via an oxidation−reduction sequence that provides an efficient multigram scale route to the β-mannopyranosides 5, 8, and 15. Reaction of glycosides 16−18 with homobifunctional adipic acid p-nitrophenyl diesters in dry DMF gave the corresponding half esters in good yields, and of sufficient stability to permit chromatographic purification. Subsequent conjugation with BSA and tetanus toxiod (TT) under mild conjugation conditions afforded the corresponding tri- and tetrasaccharide neoglycoproteins with good efficiency. The conjugation method is also applicable to the coupling of small amounts (mg) of larger oligosaccharides with different proteins.Keywords
This publication has 29 references indexed in Scilit:
- Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndromeOrganic & Biomolecular Chemistry, 2004
- Immunogenicity in a Mouse Model of a Conjugate Vaccine Made with a Synthetic Single Repeating Unit of Type 14 Pneumococcal Polysaccharide Coupled to CRM197Infection and Immunity, 2002
- Synthesis of Di- to Hexasaccharide 1,2-Linked β-Mannopyranan Oligomers, a Terminal S-Linked Tetrasaccharide Congener and the Corresponding BSA GlycoconjugatesThe Journal of Organic Chemistry, 2001
- Direct Synthesis of β-Mannans. A Hexameric [→3)-β-d-Man-(1→4)-β-d-Man-(1]3 Subunit of the Antigenic Polysaccharides from Leptospira biflexa and the Octameric (1→2)-Linked β-d-Mannan of the Candida albicans Phospholipomannan. X-ray Crystal Structure of a Protected TetramerJournal of the American Chemical Society, 2001
- Solid Phase Syntheses of Oligomannosides and of a Lactosamine Containing Milk Trisaccharide Using a Benzoate LinkerSynthesis, 2001
- Recent advances in the construction of β-D-mannose and β-D-mannosamine linkagesJournal of the Chemical Society, Perkin Transactions 1, 2000
- Fungiurie bei Krebspatienten. Analyse der Risikofaktoren, des klinischen Bildes und des Verlaufs bei 50 PatientenInfection, 1996
- One-Pot Synthesis of Substituted Allyl-α-d-Glucopyranosides by an in situ Anomerization ProtocolJournal of Carbohydrate Chemistry, 1994
- O‐Glycosylimidate, 29. Umsetzung von O‐(Glucopyranosyl)imidaten mit elektronenreichen Heterocyclen. – Synthese von C‐GlucosidenEuropean Journal of Organic Chemistry, 1987
- Synthesis of p-Nitrophenyl 4-O-(alpha-D-Mannopyranosyl)-alpha-L-rhamnoside and p-Acetamidophenyl 4-O-(beta-D-Mannopyranosyl)-alpha-L-rhamnoside.Acta Chemica Scandinavica, 1975